While Ozempic contains the active GLP-1 ingredient semaglutide, not all GLP-1 drugs are Ozempic
But people considered merely overweight, with a BMI of at least 27, are also eligible, provided they have at least one weight-related ailment, such as high blood pressure, high cholesterol or type 2 diabetes
While Novo Nordisk's global market share in GLP-1 diabetes drugs declined to 45.8% amid competitive pressure, it maintained a dominant 83.1% share of the Chinese GLP-1 market for diabetes
Glycemic control and its determinants among ambulatory patients with type 2 diabetes
Lets explore why Ozempic is so popular and examine research-backed natural options, including GLP-1 supplements, as well as other pharmaceutical and over-the-counter alternatives for your weight loss journey